Home » Topics » Regulatory » Patents

Patents
RSS

Chinese company divulges new GPR119 receptor agonists and DPP IV inhibitors

Feb. 17, 2012

Novel candidate analgesics prepared at Pfizer

Feb. 17, 2012

Japanese and Spanish university jointly develop new beta-amyloid production inhibitors

Feb. 17, 2012

Takeda reports novel NF-kappa-B activation inhibitors

Feb. 17, 2012

Genetadi Biotech presents novel integrin alpha-V/beta-3 ligands

Feb. 17, 2012

New GSNOR inhibitors and tachykinin NK3 receptor antagonists patented

Feb. 17, 2012

New aldose reductase inhibitors designed in U.S.

Feb. 17, 2012

Pfizer presents novel candidate pain treatments

Feb. 16, 2012

Bristol-Myers Squibb develops new candidate cancer therapeutics

Feb. 16, 2012

New serotonin receptor antagonists patented in Japan

Feb. 16, 2012

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...